medigraphic.com
ISSN 0016-3813 (Impreso)

2002, Número 1

<< Anterior Siguiente >>

Gac Med Mex 2002; 138 (1)


Síndromes clínicos frecuentes sin bases anatómicas. Nuevas perspectivas sobre la fibromialgia y el intestino irritable.
I. Introducción.
II. Los ritmos biológicos en la salud y en la enfermedad.
III. Síndrome de intestino irritable: Otra enfermedad sin base anatómica.
IV. La fibromialgia y el sistema nervioso autónomo.

Martínez-Lavín M, Aréchiga H, Schmulson WM, Hermosillo AG

Idioma: Español
Referencias bibliográficas: 127
Paginas: 41-56
Archivo PDF: 137.91 Kb.


FRAGMENTO

En el siglo XX, el paradigma de enfermedad estuvo basado en la correlación anatomo-clínica. Gracias a este modelo se dieron los múltiples avances en la identificación, el diagnóstico y tratamiento de un sinnúmero de enfermedades. Fue así que a un conjunto de síntomas y signos correspondía una alteración hística específica y en este ejercicio anatomo-clínico era el médico patólogo (y en años más recientes el radiólogo) quien tenía la última palabra en el diagnóstico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Hipócrates. On Airs, Waters and Places. Hippocratic Writings. Versión Inglesa, de F. Adams. The University of Chicago. 21a. Impresión, 1977, pp.9-19.

  2. Luce GG. Biological Rhythms in Human and Animal Physiology. Dover Publications, Inc, N. York, 1971,183 PP.

  3. Moore-Ede MC, Sulzman FM, Fuller CA. The Clocks that Time Us. Harvard University Press, Cambridge, Mass 1982, 488 PP.

  4. Symposia on Quantitative Biology. Vol. XXV. Long Island Biological Association, Biological Laboratory, Cold Spring Harbor, Long Island, N. York, 1960, 514 PP.

  5. Toitou Y, Haus E. (Eds.) Biological Rhythms in Clinical and Laboratory Medicine. Springer Verlag, Berlin, 1992, 730 PP.

  6. Portela A, Martin E, Aréchiga H, Cornelissen G, Sutherland D, Illera JC, Illera M, Halberg F. Cronobiología en medicina y cirugía. Gac. Med. Mex. 132;409-423:1996.

  7. Redfern P, Minors D, Waterhouse J. Circadian Rhythms, jet Iag, and chronobiotics: an overview. Chronobiol. Int. 11;253-265:1994.

  8. Monk TH. Disorders relating to shift work and jet-lag. In: Oldham, J.M., Ed. Sleep Disorders Section. Annual Review of Psychiatry, Vol. 13,1994, PP 729-756.

  9. Monk TH, Moline ML, Graeber RC. Inducing jet lag in the laboratory: patterns of adjustment to an acute shift in routine. Aviat. Space Environ. Med. 59;703-710:1988.

  10. Lloyd D, Rossi EL. (Eds.) Ultradian Rhythms. Springer-Verlag, 1992.419 PP.

  11. Bouls Z, Campbell SS, Lewy AJ, Terman M, Dijk DJ, Eastman CI. Light treatment for sleep disorders: consensus report. J. Biol. Rhythms 10;167-176:1995.

  12. Aréchiga H. Los ritmos circádicos en medicina. En: Cronobiología Médica. Martín del Campo, A. y Aréchiga, H. (Eds.) Searle Cardiovascular, 2000, PP. 9-26,

  13. Aréchiga H. Circadian Rhythms. Curr. Opin. Neurobiol. 3;1005-1010:1993.

  14. Aréchiga H, Rodríguez-Sosa L. Distributed Circadian Rhythmicity in the Crustacean Nervous System. In: Frontiers in Crustacean Neurobiology. K. Wiese Ed. Springer-Verlag (En Prensa).

  15. Klein DC, Moore RY, Reppert SM. Suprachiasmatic Nucleus: The Mind’s Clock. Oxford Univ. Press, N. York, 1991, 488 Pp.16.

  16. Stokkan KA, Yamazaki S, Tei H, Sakaki Y, Menaker M. Entrainment of the Circadian Clock in the Liver by Feeding. Science, 291;490-493:2001.

  17. Dowse HB, Ringo JM. Do Ultradian Oscillators Underlie the Circadian Clock in Drosophila?. In: Ultradian Rhythms in Life Processes. Lloyd, D. y Rossi, E.. (Eds.) Springer-Verlag, 1992, PP. 105-117.

  18. Welsh OK, Logothetis DE, Meister M, Reppert SM. Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms. Neuron 14;697-706:1995.

  19. Morse O, Hastings JW, Roenneberg T. Different phase responses of the two circadian oscillators in Gonyaulax. J. Biol. Rhythms 94;263-274:1994.

  20. Golden SS, Ishiura M, Johnson CH, Kondo T. Cyanobacterial Circadian Rhythms. Annu. Rev. Plant. Physiol. Plant. Mol. Biol. 48;327-354:1997.

  21. Dunlap J. Molecular bases for circadian clocks. Cell 271-290,1999.

  22. Wisor J, Takahashi JS. Molecular Genetic Approaches to the Identity and Function of Circadian Clock Genes. In Regulation of Sleep and Circadian Rhythms. Turek, F.W. y Zee, Ph. C. (Eds.) Marcel Dekker (inc.). N. York, Basel, 1999;PP:369-395.

  23. Shearman LP, Sriram SI, Weaver DR, Maywood ES, Chaves I, Zheng B, Kume K, Lee Ch, van der Horst GTJ, Hastings MH, Reppert SM. Interacting Molecular Loops in the Mammalian Circadian Clock. Science 288 (5468);1013-1019:2000.

  24. Moore RY. Entrainment pathways and functional organization of the circadian system. Prog. Brain Res. 111;103-119:1996.

  25. Komhauser J, Ginty D, Greenberg M, Mayo K, Takahashi J. Light entrainment and activation signal transduction pathways in the SCN. Prog. Brain Res. 111;134-146:1996.

  26. Aréchiga H. Neuronal Mechanisms of Biological Rhythms. In: Time, Internal Clocks, and Movement. Pastor, M.A. y Artieda, J. (Eds.) Elsevier, 1996, PP.95-114.

  27. Plautz JD, Kaneko M, Hall JC, Kay SA. lndependent Photoreceptive Circadian Clocks Throughout Drosophila, Science 278;1632-1635:1997.

  28. Walchulec M, Li H, Tanaka H, Peloso E, Satinoff E. Suprachiasmatic Nuclei Lesions do not Eliminate Homeostatic Thermoregulatory Responses in Rats. J. Biol. Rhythms 12;226-234:1997.

  29. Fernández de Miguel F, Aréchiga H. Circadian Locomotor Activity and its Entrainment by Food in the Crayfish Procambarus clarkii. J. exp. Biol 190;9-21:1994.

  30. McArthur A, Gillette M, Prosser R. Melatonin directly resets the rat suprachiasmatic circadian clock in vitro. Brain Res. 656;158-161:1991.

  31. Penev PD, Zee PC. Melatonin: A clinical Perspective. Ann. Neurol 42:545-553,1997.

  32. Waterhouse J, Reilly T, Atkinson G. Jet-lag. Lancet 350;161-1616:1997.

  33. Meyer-Bernstein E, Morin L. Differential serotonergic innervation of the suprachiasmatic nucleus and the intergeniculate leaflet and its role in circadian rhythm modulation. J. Neurosci. 16;2097-2111::1996.

  34. Lemmer B. (Ed.). From the Biological Clock to Chronopharmacology. Medpharm Scientific Publishers. Stutgart, 1996,206 PP.

  35. Levi F. Chronopharmacology of Anticancer Agents. In: Handbook of Experimental Pharmacology. Ph. Redfern y B. Lemmer, Eds. Springer Verlag, Berlin, 1997 Capítulo 11.

  36. Sánchez de la Peña S. Cronoterapia del Cáncer. En: Cronobiología Médica. Martín del Campo, A. y Aréchiga, H. (Eds). Searle Cardiovascular, 2000, PP 180-201.

  37. Cugini P, Di Palma L, Battisti P, Leone G. Ultradian, circadian and infradian periodicity of some cardiovascular emergencies. Am. J. Cardiol. 66;240-243:1990.

  38. Qtsuka K, Cornelissen G, Halberg F. (Eds.) Chronocardiology and Chronomedicine. Life Science Publishing Co. Ltd. Tokyo, 1993. PP 138.

  39. Deedwania P. (Eds.) Circadian Rhythms of Cardiovascular Disorders. Futura Publishing Company Inc. Armonk, N.Y., 1997 PP. 221.

  40. Martínez-Lavín M, HermoSIIlo AG, Rosas M, Soto ME. Circadian studies of autonomic nervous balance in patients with fibromyalgia. Arthritis and Rheumatism 41:1966-1971.

  41. Freston JW. Emerging strategies for managing peptic ulcer disease. Scand. J. Gastroenterol. 29 (Suppl. 201);49-54:1994.

  42. Steindl PE, Finn B, Bendok B, Rothke S, Zee PC, Blei AT. Disruption of the diurnal rhythm of plasma melatonin in cirrhosis. Ann. lnt. Med. 123;274-277:1995.

  43. Solomon GD. Circadian Rhythms and Migraine. Cleveland Clin. J.Med. 59;326-329:1992.

  44. Compston DAS. The Management of Multiple Sclerosis. Q.J. Med. 70;93-101:11989.

  45. Shouze MN, Da SiIva MA, Samaritano M. Circadian Rhythms, Sleep, and Epilepsy. J. Clin. Neurophysiol. 13;32-50:1996.

  46. Zee PhC, Grujic Z. Neurological Disorders Associated with Disturbed Sleep and Circadian Rhythms. In: Regulation of Sleep and Circadian Rhythms. F.W. Turek y Ph. C. (Eds.) Marcel Dekker, Inc. N. York, Basel, 1999, PP. 557-596.

  47. Lewy AJ, Sack RL, Miller L, Hoban T. Antidepressant and circadian phase-shiffing effects of light. Science 235;352-354:1987.

  48. Wirz-Justice A. Biological rhythms in mood disorders. In: Bloom, F.E. y Kupfer, D.J. (Eds.) Psychopharmacology: The Third Generation of Progress. Raven Press, N. York, 1995, PP. 999-1017.1. Mayer EA. Emerging disease model for functional gastrointestinal disorders. Am. J. Med. 1999;107(5A):12S-19S.

  49. Schmulson M, Robles G, Kershenobich D, Lopez-Ridaura R, Hinojosa C, Duarte A, Bandera J. Los pacientes con trastornos funcionales digestivos (TFD) tienen mayor compromiso de la calidad de vida (CV) evaluada por el SF-36 comparados con pacientes con hepatitis C y pancreatitis crónica. Rev. Gastroenterol. Méx. 2000;65:50.

  50. Powell R. On certain painful afflictions of the intestinal canal. Med. Trans. R. Coll. Phys. 1818;6:106.

  51. Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129-36.

  52. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable bowel syndrome. Gut 1973;6:105-112.

  53. Schmulson MJ, Valdovinos MA. Utilización de recursos médicos por los pacientes con síndrome de intestino irritable en un hospital de tercer nivel. Rev. Gastroenterol. Méx. 1998;63(1):6-10.

  54. Mertz H, Naliboff B, Munakata J, Niaz N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109:40-52.

  55. Mayer EA, Gebhart GF. Functional bowel disorders and the visceral hyperalgesia hypothesis. In: Mayer EA, Raybould HE, eds. Basic and clinical aspects of chronic abdominal pain. Vol. 9, 1st. ed. Amsterdam: Elsevier, 1993:3-28.

  56. Schmulson M, Mayer EA. Evolving concepts in irritable bowel syndrome. Curr. Opin. Gastroenterol. 1999;15:16-21.

  57. Harraf F, Schmulson M, Saba L, Niazi N, Fass R, Munakata J, Diehl D, Mertz H, Naliboff B, Mayer EA. Subtypes of constipation predominant irritable bowel syndrome based on rectal perception. Gut 1998;43:388-394.

  58. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine E, Müller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999, 45(Suppl. II):1143-1147.

  59. Tanimoto MA, Schmulson M, Ramirez-Degollado J, Valdovinos MA. Prevalencia de trastornos funcionales del tubo digestivo en estudiantes de medicina. Rev. Gastroenterol. Méx. 1995;60 (Supl. 3):S78.

  60. Lee OY, Schmulson M, Mayer EA, Chang L, Naliboff B. Gender related differences in irritable bowel syndrome symptoms. Gastroenterology 1999;116(Part 2):A1026 (34457).

  61. Ocampo MA, Milke P, Valdovinos MA, Schmulson M. El chile en la dieta disminuye el umbral sensorial rectal evaluado por barostato en pacientes con síndrome de colon irritable (SCI). Rev. Gastroenterol. Méx. 2000;65(Resúmenes):67.

  62. Schmulson M, Lee OY, Chang L, Eisenstein E, Fullerton S, Naliboff B, FitzGerald L, Munakata J, Mayer EA. Food intake does not change rectal perception in IBS-diarrhea predominant patients. Am. J. Gastroenterol. 1998;93(9):A361.

  63. Schmulson M, Chang L. Diagnostic approach to the patient with irritable bowel syndrome. Am. J .Med. 1999;107(Supp. 5A):20s-26s.

  64. Schmulson M, Chang L, Naliboff B, Lee OY, Mayer EA. Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients. Am. J Gastroenterol. 2000:95:152-156.

  65. Schmulson M, Lee OY, Chang L, Naliboff B, Mayer EA. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am. J. Gastroenterol. 1999;94:2929-2935.

  66. Lembo T, Naliboff B, Munakata J, Fullerton S, Saba L, Tung S, Schmulson M, Mayer EA. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am. J. Gastroenterol. 1999;94:1320-1326.

  67. Lee OY, Mayer EA, Chang L, Naliboff B. Ratings of sigmoid but not rectal distensions correlate with IBS symptom severity. Gastroenterology 2000;118(Suppl.2): A445-2439.

  68. Chang L, Mayer EA, Johnson T, FitzGerald L, Naliboff B. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain 2000;84:297-307.

  69. Chang L, Lembo T, Naliboff B, Schmulson M, Mayer EA. Differences in perceptual responses to thermal and mechanical pain in female patients with irritable bowel syndrome (IBS). Gastroenterology 1999;116(Part 2):A969-G4217.

  70. Silverman DHS, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology 1997;112:64-72.

  71. Mayer EA, Naliboff B, Lee OY, Munakata J, Chang L. Review article: gender-related differences in functional gastrointestinal disorders. Aliment. Pharmacol. Ther. 1999;13(Suppl. 2):65-69.

  72. Munakata J, Silverman DH, Naliboff B, Berman S, Mayer EA. Evidence for cortical visceral dysregulation in irritable bowel syndrome. Neurogastroenterology and Motility. 1998;10:362(A14).

  73. Aggarwal A, Cutts TF, Abell TL, et al. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology 1994;106:945-50.

  74. Schmulson M, Lee OY, Olivas T, Chang L, Fitzgerald L, Naliboff B, Mayer EA. Effect of food intake on rectosigmoid motor and perceptual responses in IBS patients with different bowel habit. Gastroenterology 1999,116 (Part 2):A1078 (34683).

  75. Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut 2000;47:861-9.

  76. Munakata JI Mayer EA, Chang L, Schmulson M, Liu M, Tougas G, Kamath M, Naliboff B. Autonomic and neuroendocrine responses to recto-sigmoid stimulation. Gastroenterology 1998;114(Part 2):A808-G3322.

  77. Orr WC, Elsenbruch S, Harnish MJ. Autonomic regulation of cardiac function during sleep in patients with irritable bowel syndrome. Am. J. Gastroenterol. 2000;95:2865-72.

  78. Chang L, Poland R, Naliboft B, Schmulson M, Fitzgerald L, Mayer EA. Decreased slow wave sleep activity in female patients with irritable bowel syndrome (IBS) and fibromyalgia (FM). Gastroenterology 1999;116(Part 2):A969-G4218.

  79. Vogel GW, Buifenstein A, Minter K, et al. Drug effects on REM endogenous depression. Neurosci. Biobehav. Rev. 1999;14:49-63.

  80. Gershon MD. Review article. Roles played by 5-hydroxytryptamine in of bowel. Aliment. Pharmacol. Ther 1999;13(Suppl.2):15-30.

  81. Camillen M, Northcult A, Kong S, Dukes G, McSorley D, Mangel A. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomized, placebo-controlled trial. Lancet 2000;355:1035-39.

  82. Naliboff B, Chang L, Mandelkern M, Hamm L, Mayer EA. Evidence for selective effect of the 5-HT3 antagonist alosetron on amygdala and hyppocampal activation in IBS patients. Gastroenterology. 2000;118 (Suppl.2):A81.

  83. Prather CM, Camillen M, Zinsmeister AR, et al. Gastroenterology

  84. Bearcroft CP, Perrett D, Farthing MJ. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 1998;42:42-46.

  85. Spiller RC, Jenkins JP, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR. Increased rectal mucosal enteroendocrine cells, T Lymphocytes, and increased gut sleep and on the physiology permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-11.

  86. Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever U. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol. Psych. 40;79-88:1996.

  87. Martín del Campo A. Cronobiología y Psiquiatría. En: Cronobiología Médica. Martín del Campo, A. y Aréchiga, H. (Eds.). Searle Cardiovascular, 2000, PP. 42-55.

  88. Smolensky MH, D’Alonzo GE. Medical Chronobiology: Concepts and Applications. Am. Rev. Respir. Dis. 147;52-519:1993.

  89. Rodríguez C, Revilla MA, Revilla M, Revilla E, Cornelissen G, Aréchiga H, Halberg F. El perfil cronobiológico de tensión arterial y de frecuencia cardiaca en un grupo familiar, determinado mediante monitorización automática. Gac. Med. Mex. 134;15-26:1998.

  90. Mayer EA. Emerging disease model for functional gastrointestinal disorders. Am. J. Med. 1999;107(5A):12S-19S.

  91. Schmulson M, Robles G, Kershenobich D, Lopez-Ridaura R, Hinojosa C, Duarte A, Bandera J. Los pacientes con trastornos funcionales digestivos (TFD) tienen mayor compromiso de la calidad de vida (CV) evaluada por el SF-36 comparados con pacientes con hepatitis C y pancreatitis crónica. Rev. Gastroenterol. Méx. 2000;65:50.

  92. Powell R. On certain painful afflictions of the intestinal canal. Med. Trans. R. Coll. Phys. 1818;6:106.

  93. Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129-36.

  94. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable bowel syndrome. Gut 1973;6:105-112.

  95. Schmulson MJ, Valdovinos MA. Utilización de recursos médicos por los pacientes con síndrome de intestino irritable en un hospital de tercer nivel. Rev. Gastroenterol. Méx. 1998;63(1):6-10.

  96. Mertz H, Naliboff B, Munakata J, Niaz N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109:40-52.

  97. Mayer EA, Gebhart GF. Functional bowel disorders and the visceral hyperalgesia hypothesis. In: Mayer EA, Raybould HE, eds. Basic and clinical aspects of chronic abdominal pain. Vol. 9, 1st. ed. Amsterdam: Elsevier, 1993:3-28.

  98. Schmulson M, Mayer EA. Evolving concepts in irritable bowel syndrome. Curr. Opin. Gastroenterol. 1999;15:16-21.

  99. Harraf F, Schmulson M, Saba L, Niazi N, Fass R, Munakata J, Diehl D, Mertz H, Naliboff B, Mayer EA. Subtypes of constipation predominant irritable bowel syndrome based on rectal perception. Gut 1998;43:388-394.

  100. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine E, Müller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999, 45(Suppl. II):1143-1147.

  101. Tanimoto MA, Schmulson M, Ramirez-Degollado J, Valdovinos MA. Prevalencia de trastornos funcionales del tubo digestivo en estudiantes de medicina. Rev. Gastroenterol. Méx. 1995;60 (Supl. 3):S78.

  102. Lee OY, Schmulson M, Mayer EA, Chang L, Naliboff B. Gender related differences in irritable bowel syndrome symptoms. Gastroenterology 1999;116(Part 2):A1026 (34457).

  103. Ocampo MA, Milke P, Valdovinos MA, Schmulson M. El chile en la dieta disminuye el umbral sensorial rectal evaluado por barostato en pacientes con síndrome de colon irritable (SCI). Rev. Gastroenterol. Méx. 2000;65(Resúmenes):67.

  104. Schmulson M, Lee OY, Chang L, Eisenstein E, Fullerton S, Naliboff B, FitzGerald L, Munakata J, Mayer EA. Food intake does not change rectal perception in IBS-diarrhea predominant patients. Am. J. Gastroenterol. 1998;93(9):A361.

  105. Schmulson M, Chang L. Diagnostic approach to the patient with irritable bowel syndrome. Am. J .Med. 1999;107(Supp. 5A):20s-26s.

  106. Schmulson M, Chang L, Naliboff B, Lee OY, Mayer EA. Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients. Am. J Gastroenterol. 2000:95:152-156.

  107. Schmulson M, Lee OY, Chang L, Naliboff B, Mayer EA. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am. J. Gastroenterol. 1999;94:2929-2935.

  108. Lembo T, Naliboff B, Munakata J, Fullerton S, Saba L, Tung S, Schmulson M, Mayer EA. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am. J. Gastroenterol. 1999;94:1320-1326.

  109. Lee OY, Mayer EA, Chang L, Naliboff B. Ratings of sigmoid but not rectal distensions correlate with IBS symptom severity. Gastroenterology 2000;118(Suppl.2): A445-2439.

  110. Chang L, Mayer EA, Johnson T, FitzGerald L, Naliboff B. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain 2000;84:297-307.

  111. Chang L, Lembo T, Naliboff B, Schmulson M, Mayer EA. Differences in perceptual responses to thermal and mechanical pain in female patients with irritable bowel syndrome (IBS). Gastroenterology 1999;116(Part 2):A969-G4217.

  112. Silverman DHS, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology 1997;112:64-72.

  113. Mayer EA, Naliboff B, Lee OY, Munakata J, Chang L. Review article: gender-related differences in functional gastrointestinal disorders. Aliment. Pharmacol. Ther. 1999;13(Suppl. 2):65-69.

  114. Munakata J, Silverman DH, Naliboff B, Berman S, Mayer EA. Evidence for cortical visceral dysregulation in irritable bowel syndrome. Neurogastroenterology and Motility. 1998;10:362(A14).

  115. Aggarwal A, Cutts TF, Abell TL, et al. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology 1994;106:945-50.

  116. Schmulson M, Lee OY, Olivas T, Chang L, Fitzgerald L, Naliboff B, Mayer EA. Effect of food intake on rectosigmoid motor and perceptual responses in IBS patients with different bowel habit. Gastroenterology 1999,116 (Part 2):A1078 (34683).

  117. Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut 2000;47:861-9.

  118. Munakata JI Mayer EA, Chang L, Schmulson M, Liu M, Tougas G, Kamath M, Naliboff B. Autonomic and neuroendocrine responses to recto-sigmoid stimulation. Gastroenterology 1998;114(Part 2):A808-G3322.

  119. Orr WC, Elsenbruch S, Harnish MJ. Autonomic regulation of cardiac function during sleep in patients with irritable bowel syndrome. Am. J. Gastroenterol. 2000;95:2865-72.

  120. Chang L, Poland R, Naliboft B, Schmulson M, Fitzgerald L, Mayer EA. Decreased slow wave sleep activity in female patients with irritable bowel syndrome (IBS) and fibromyalgia (FM). Gastroenterology 1999;116(Part 2):A969-G4218.

  121. Vogel GW, Buifenstein A, Minter K, et al. Drug effects on REM endogenous depression. Neurosci. Biobehav. Rev. 1999;14:49-63.

  122. Gershon MD. Review article. Roles played by 5-hydroxytryptamine in of bowel. Aliment. Pharmacol. Ther 1999;13(Suppl.2):15-30.

  123. Camillen M, Northcult A, Kong S, Dukes G, McSorley D, Mangel A. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomized, placebo-controlled trial. Lancet 2000;355:1035-39.

  124. Naliboff B, Chang L, Mandelkern M, Hamm L, Mayer EA. Evidence for selective effect of the 5-HT3 antagonist alosetron on amygdala and hyppocampal activation in IBS patients. Gastroenterology. 2000;118 (Suppl.2):A81.

  125. Prather CM, Camillen M, Zinsmeister AR, et al. Gastroenterology

  126. Bearcroft CP, Perrett D, Farthing MJ. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 1998;42:42-46.

  127. Spiller RC, Jenkins JP, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR. Increased rectal mucosal enteroendocrine cells, T Lymphocytes, and increased gut sleep and on the physiology permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-11.




2020     |     www.medigraphic.com